Related Experiment Video
Updated: Jun 5, 2025

05:43
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
Published on: January 10, 2025
443
Comparison of different nebulisation systems for capsaicin cough challenge testing.
Kimberley J Holt1,2, Joanne Mitchell2, Rachel J Dockry1,2
1Division of Infection, Immunity and Respiratory Medicine, University of Manchester and Manchester Academic Health Science Centre, Manchester, UK.
ERJ Open Research
|December 10, 2024
Summary
The Provo.X nebulisation system effectively measures cough responses to capsaicin, proving comparable to older methods. This makes it a suitable device for future cough challenge research.
Area of Science:
- Respiratory physiology
- Pharmacology
- Medical device evaluation
Background:
- Cough reflex hypersensitivity is a key feature of various respiratory conditions.
- Accurate measurement of cough responses is crucial for diagnosis and treatment evaluation.
- The KoKo dosimeter was a standard but is now obsolete.
Purpose of the Study:
- To evaluate the performance of the Provo.X nebulisation system.
- To compare the Provo.X system with the KoKo dosimeter for capsaicin cough challenge studies.
- To determine the suitability of the Provo.X system for future research.
Main Methods:
- Cough responses to capsaicin were measured using both the Provo.X nebulisation system and the KoKo dosimeter.
- Participants underwent standardized capsaicin cough challenge protocols.
- Data from both devices were compared for comparability.
Main Results:
- The Provo.X nebulisation system demonstrated comparable results to the KoKo dosimeter in measuring cough responses.
- The system showed reliability in delivering capsaicin for cough challenge testing.
- No significant differences were observed between the two devices.
Conclusions:
- The Provo.X nebulisation system is a viable and acceptable alternative to the obsolete KoKo dosimeter.
- This device can be reliably used in future capsaicin-induced cough challenge studies.
- The findings support the adoption of the Provo.X system in clinical research settings.

